Tourmaline Bio, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Tourmaline Bio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q4 2023.
  • Tourmaline Bio, Inc. Operating Lease, Payments for the quarter ending December 31, 2023 was -$700K, a 333% decline year-over-year.
  • Tourmaline Bio, Inc. Operating Lease, Payments for the twelve months ending December 31, 2023 was $200K, a 77.8% decline year-over-year.
  • Tourmaline Bio, Inc. annual Operating Lease, Payments for 2023 was $200K, a 77.8% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $200K -$700K -$1M -333% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $1.2M $300K +$100K +50% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.1M $300K +$100K +50% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1M $300K +$100K +50% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $900K $300K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $200K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $200K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $200K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.